Ask questions and gain insights about this stock now with Rize AI
COO logo

The Cooper Companies, Inc.

COO

Stock Analysis

$71.97

+0.00 (+0.00%)• Live

The Cooper Companies, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics

Historical Prices

for The Cooper Companies, Inc.

Key Financial Metrics

for The Cooper Companies, Inc.

2024 FY
P/E Ratio
34.47
Revenue Growth
+8.41%
EPS Growth
+32.21%
Market Cap
$14.25B
Dividend Yield
0.00%
Debt/Equity
0.31
ROIC
+4.35%
FCF Yield
+2.57%
View additional metrics

Valuation

P/B Ratio1.72
EV/Sales4.19

Financial Health

Current Ratio2.10
Return on Assets+6.04%

Analyst Recommendations

for The Cooper Companies, Inc.

23 analysts
Consensus: Buy

About

for The Cooper Companies, Inc.

Company Details

for The Cooper Companies, Inc.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Albert G. White III

Employees

16,000

Market Cap

14.36B

Exchange

NASDAQ Global Select

IPO Date

January 21, 1983

CIK

0000711404

ISIN

US2166485019

CUSIP

216648402

Country

US

Balance Sheet

for The Cooper Companies, Inc.

Cash Flow Statement

for The Cooper Companies, Inc.

Income Statement

for The Cooper Companies, Inc.

Rize ist ein KI-gestütztes Investment-Research-Terminal, das eine umfassende Aktienanalyse und Einblicke über ein intuitives Dashboard bietet.

News

No news available at the moment.